Rizzello, I., Cavo, M., Dozza, L., Rivolti, E., Petrucci, M. T., De Stefano, V., Antonioli, E., Tosi, P., D'Agostino, M., Morè, S., Gozzetti, A., Cea, M., Barbato, S., Tacchetti, P., Pantani, L., Mancuso, K., Rocchi, S., De Cicco, G., Fusco, A., & Zamagni, E. (2021). subcutaneous bortezomib-containing regimens as up-front treatment of newly diagnosed transplant-eligible multiple myeloma patients: a retrospective, non-interventional observational study. Leukemia & lymphoma, 62(8), 1897–1906. http://access.bl.uk/ark:/81055/vdc_100139607792.0x00003d